Zhigang S. Liu
45 Chengde Street
Chengde, 132022, China
Chengde, 132022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
A lysosome-targeted dual-response fluorescent probe for malondialdehyde and formaldehyde and its application in drug-induced liver injury.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: June 16, 2026
Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: April 21, 2026
Supramolecular Engineering of a Homo[2]catenane Filler Enables Polymer Composites with Exceptional High-Temperature Capacitive Energy Storage.
Journal: Molecules (Basel, Switzerland)
Published: April 14, 2026
Long-Term Outcomes of Concurrent Chemoradiotherapy With S-1 in Older Patients With Esophageal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: March 27, 2026
Ultra-Radiostable Covalent Conformationally Interlocked Networks Enabling a Universal Radiometal-Labeling Platform for Cancer Radioembolization.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 05, 2026
Development of a novel fluorescent probe for highly sensitive detection and visualization of HClO in environmental and biological systems.
Journal: Physical chemistry chemical physics : PCCP
Published: December 24, 2025
Lignin-based Fe/Zn bimetallic Fenton-like catalysts for efficient degradation of tetracycline in water.
Journal: International journal of biological macromolecules
Published: November 17, 2025
A Golgi-targeted regenerated fluorescence probe for the detection of formaldehyde and its imaging applications in living cells and zebrafish.
Journal: Bioorganic chemistry
Published: September 23, 2025
Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma.
Journal: Cancer treatment reviews
Published: September 08, 2025
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China.
Journal: Lancet (London, England)
Published: September 08, 2025
Humic acid-based Fe/Ag bimetallic Fenton-like catalysts for efficient degradation of sulfadiazine in water.
Journal: International journal of biological macromolecules
Published: May 20, 2025
Last Updated: 09/26/2026